Bill Filed to Expand Law Concerning Pro-Life Cities, Counties in Arkansas

On Thursday lawmakers filed a bill to help expand Pro-Life political subdivisions in Arkansas.

S.B. 446 by Sen. Josh Bryant (R – Rogers) and Rep. Kendon Underwood (R – Cave Springs) builds on Arkansas’ law that lets cities and counties pass Pro-Life resolutions.

Act 392 of 2021 by Rep. Kendon Underwood (R – Cave Springs) and Sen. Gary Stubblefield (R – Branch) affirms that cities and counties can designate themselves as Pro-Life. To date, nearly half of all Arkansans live in a Pro-Life City or Pro-Life County.

S.B. 446 expands this 2021 law so that any political subdivision of the state can declare itself to be Pro-Life — not just a city or a county.

Now that the U.S. Supreme Court has reversed Roe v. Wade and abortion is generally prohibited in Arkansas, citizens and their elected officials need to establish exactly where they stand when it comes to protecting innocent human life.

S.B. 446 is a good bill that will help communities do exactly that.

You Can Read S.B. 446 Here.

Arkansas Senate Passes Bill Prohibiting Delta-8 and Other Drugs Made From Cannabis

On Wednesday the Arkansas Senate passed a bill that would prohibit Delta-8 THC in Arkansas.

S.B. 358 by Sen. Tyler Dees (R – Siloam Springs) and Rep. Jimmy Gazaway (R – Paragould) would prevent Delta-8 THC from being manufactured or sold by placing it and other psychoactive drugs made from cannabis on the list of controlled substances in state law.

Delta-8 THC is a mind-altering substance made from cannabis, and Arkansas law does not adequately prohibit it.

S.B. 358 also contains language enacting drug restrictions that would take effect if a state or federal court someday blocked Arkansas from prohibiting Delta-8 altogether.

The bill now goes to the Arkansas House of Representatives for consideration.

The Following Senators Voted For S.B. 358

  • J. Boyd
  • J. Bryant
  • Caldwell
  • L. Chesterfield
  • A. Clark
  • Crowell
  • B. Davis
  • Dees
  • J. Dismang
  • J. Dotson
  • J. English
  • Flippo
  • Gilmore
  • K. Hammer
  • Hester
  • Hickey
  • Hill
  • Irvin
  • B. Johnson
  • M. Johnson
  • B. King
  • F. Love
  • M. McKee
  • R. Murdock
  • J. Payton
  • C. Penzo
  • J. Petty
  • Rice
  • Stone
  • G. Stubblefield
  • D. Sullivan
  • C. Tucker
  • D. Wallace

The Following Senator Voted Against S.B. 358

  • G. Leding

The Following Senator Voted “Present” on S.B. 358

  • S. Flowers

Gov. Sanders Signs Law Protecting Children From Malpractice in Sex-Change Procedures

On Monday Gov. Sarah Sanders signed a law that will help protect children from medical malpractice in dangerous sex-change procedures.

S.B. 199 — which is is now Act 274 of 2023 — by Sen. Gary Stubblefield (R – Branch) and Rep. Mary Bentley (R – Perryville) lets a child who undergoes a sex-change procedure sue the healthcare provider who performed procedure if the child suffers any injury as a result.

Act 274 would let a child file a lawsuit if he or she experiences:

  • A physical or physiological injury from the sex-change procedure
  • A psychological or emotional injury from the sex-change procedure
  • An injury from treatments related to the sex-change procedure
  • An injury from the after-effects of the sex-change procedure

Act 274 also outlines informed-consent processes for sex-change surgeries, puberty blockers, and cross-sex hormones, and it contains protections for healthcare providers who decline to perform sex-reassignment procedures.

More and more, scientific evidence shows sex-reassignment procedures are harmful to children.

Research published this year calls into question the original studies that encouraged doctors to give puberty blockers and cross-sex hormones to children with gender dysphoria.

In 2021 a major hospital in Sweden announced that it would no longer give puberty blockers and cross-sex hormones to kids.

Last year the U.K.’s National Health Services closed its Tavistock gender clinic that gave puberty blockers and cross-sex hormones to children for many years. Families have indicated their children were subjected to sex-reassignment at that clinic despite an obvious lack of scientific evidence in favor of the procedures and inadequate mental health screenings for children with gender dysphoria.

A gender-identity clinic in Scotland faces similar accusations from former patients who say healthcare professionals rushed them into sex-change procedures.

And last July the U.S. Food and Drug Administration finally added a warning label to puberty blockers in America after biological girls developed symptoms of tumor-like masses in the brain.

Act 274 will help protect children, and it will provide them and their families with legal recourse if they are injured by a sex-change procedure.